ANGES, INC./ JP3127700007 /
2024-03-28 9:48:04 AM | Chg. 0.0000 | Volume | Bid9:54:11 PM | Ask9:40:11 PM | High | Low |
---|---|---|---|---|---|---|
0.3800EUR | 0.00% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 0.3800 | 0.3800 |
GlobeNewswire
02-07
Artios Pharma Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Fi...
GlobeNewswire
2021-09-23
Brilliant Matters announces Strategic Investment to Accelerate Production of their High-Performing, ...
GlobeNewswire
2021-05-03
Excision BioTherapeutics Appoints Seasoned Finance Executive Christine Silverstein as Chief Financia...
GlobeNewswire
2021-04-16
Brickell Biotech Announces Presentation of US Phase 3 Open-Label Long-Term Safety Study Results for ...
GlobeNewswire
2021-03-09
Brickell Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate ...
GlobeNewswire
2020-11-18
Brickell Biotech Announces Launch Date for Sofpironium Bromide Gel, 5% (ECCLOCK®) in Japan by its De...
GlobeNewswire
2020-11-12
Brickell Biotech Reports Third Quarter 2020 Financial Results and Provides Corporate Update
GlobeNewswire
2020-09-23
Innovator ETFs Announces Upside Cap Ranges for October Series of Defined Outcome ETFs
GlobeNewswire
2020-09-08
AnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA Vac...
GlobeNewswire
2019-10-10
Worldwide DNA Read, Write & Edit Markets to 2024 | Technologies, Applications, Innovations, Patents,...
GlobeNewswire
2019-05-23
Global Infectious Vaccines Partnering Deal Trends, Players and Financials 2019 - Access to Over 250 ...
GlobeNewswire
2019-04-05
AnGes Obtains Conditional Approval in Japan for HGF Gene Therapy to Treat Critical Limb Ischemia
GlobeNewswire
2018-12-17
Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...
GlobeNewswire
2018-08-13
Gene Therapy Market, 2018-2030 - Around 300 Product Candidates Under Various Stages of Development f...
GlobeNewswire
2018-07-31
Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreem...
GlobeNewswire
2018-07-31
Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreem...